NDC 0006-3061

EMEND

Fosaprepitant Dimeglumine

EMEND is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Merck Sharp & Dohme Llc. The primary component is Fosaprepitant Dimeglumine.

• Product ID: 0006-3061_1686c188-89cb-401b-8db9-56c29b521ff4
• NDC: 0006-3061
• Product Type: Human Prescription Drug
• Proprietary Name: EMEND
• Generic Name: Fosaprepitant Dimeglumine
• Dosage Form: Injection, Powder, Lyophilized, For Solution
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2017-02-03
• Marketing Category: NDA / NDA
• Application Number: NDA022023
• Labeler Name: Merck Sharp & Dohme LLC
• Substance Name: FOSAPREPITANT DIMEGLUMINE
• Active Ingredient Strength: 150 mg/5mL
• Pharm Classes: Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 0006-3061-00

1 VIAL, SINGLE-DOSE in 1 CARTON (0006-3061-00) > 5 mL in 1 VIAL, SINGLE-DOSE (0006-3061-01)

• Marketing Start Date: 2017-02-03
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0006-3061-01 [00006306101]

EMEND INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

• Marketing Category: NDA
• Application Number: NDA022023
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2017-02-03

NDC 0006-3061-00 [00006306100]

EMEND INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

• Marketing Category: NDA
• Application Number: NDA022023
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2017-02-03

NDC 0006-3061-02 [00006306102]

EMEND INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

• Marketing Category: NDA
• Application Number: NDA022023
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2017-02-03

NDC 0006-3061-04 [00006306104]

EMEND INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

• Marketing Category: NDA
• Application Number: NDA022023
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2017-02-03

Drug Details

Active Ingredients

Ingredient	Strength
FOSAPREPITANT DIMEGLUMINE	150 mg/5mL

OpenFDA Data

• SPL SET ID: 8d66803a-6811-4c29-9c57-e16acfa87f21
• Manufacturer:
  • Merck Sharp & Dohme Corp.
• UNII:
  • D35FM8T64X
• RxNorm Concept Unique ID - RxCUI:
  • 1731077
  • 1731082

Pharmacological Class

• Neurokinin 1 Antagonists [MoA]
• Substance P/Neurokinin-1 Receptor Antagonist [EPC]
• Cytochrome P450 3A4 Inhibitors [MoA]
• Cytochrome P450 2C9 Inducers [MoA]
• Cytochrome P450 3A4 Inducers [MoA]

NDC Crossover Matching brand name "EMEND" or generic name "Fosaprepitant Dimeglumine"

NDC	Brand Name	Generic Name
0006-0461	EMEND	aprepitant
0006-0462	EMEND	aprepitant
0006-0464	EMEND	aprepitant
0006-3061	EMEND	FOSAPREPITANT DIMEGLUMINE
0006-3066	EMEND	aprepitant
0006-3862	EMEND	aprepitant
0006-3941	EMEND	EMEND
42254-160	EMEND	EMEND